Orser Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Orser Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,796	Closed	-$251K	–	83
2022 Q1	$251K	Buy	2,796 +480	+21%	+$44.3K	0.15%	77
2021 Q4	$259K	Sell	2,316 -980	-30%	-$118K	0.13%	84
2021 Q3	$414K	Sell	3,296 -7,867	-70%	-$1.01M	0.23%	68
2021 Q2	$1.51M	Buy	11,163 +3,181	+40%	+$418K	0.78%	48
2021 Q1	$1.08M	Buy	7,982 +3,239	+68%	+$485K	0.7%	47
2020 Q4	$668K	Buy	4,743 +1,820	+62%	+$233K	0.42%	60
2020 Q3	$326K	Buy	+2,923	New	+$328K	0.26%	61
2020 Q2	–	Sell	-2,643	Closed	-$205K	–	65
2020 Q1	$205K	Sell	2,643 -9,591	-78%	-$849K	0.29%	55
2019 Q4	$1.16M	Buy	12,234 +8,580	+235%	+$742K	1.12%	35
2019 Q3	$287K	Hold	3,654	–	–	0.34%	56
2019 Q2	$336K	Sell	3,654 -263	-7%	-$22.4K	0.35%	54
2019 Q1	$355K	Sell	3,917 -770	-16%	-$65.5K	0.39%	53
2018 Q4	$411K	Hold	4,687	–	–	0.47%	52
2018 Q3	$411K	Buy	4,687 +720	+18%	+$69.8K	0.39%	62
2018 Q2	$399K	Sell	3,967 -1,635	-29%	-$150K	0.35%	72
2018 Q1	$496K	Sell	5,602 -12,085	-68%	-$1.1M	0.46%	65
2017 Q4	$1.56M	Buy	+17,687	New	+$1.48M	1.39%	33

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Orser Capital Management's XBI Position: Q2 2022 in Review

Orser Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 2,796 shares — an estimated $251K sold.

Orser Capital Management first reported a position in XBI in Q4 2017 and held it in 17 quarters. The position peaked at $1.56M in Q4 2017. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Orser Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Orser Capital Management sold 2,796 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $251K.
Orser Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 17 quarters.
Orser Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.56M in Q4 2017.
706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Orser Capital Management's 13F filing for Q2 2022, filed 11 Jul 2022.